Loading clinical trials...
Loading clinical trials...
Effects of Danning Tablet Under Lifestyle Intervention in Patients With Polypoid Lesions of Gallbladder: A Randomized, Open-labelled, Multicenter, Controlled Trial
Conditions
Interventions
Danning Tablet
Locations
18
China
The Second Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Xiangya Changde Hospital
Changde, Hunan, China
The First Affiliated Hospital of University of South China
Hengyang, Hunan, China
Loudi Central Hospital
Loudi, Hunan, China
Yiyang Central Hospital
Yiyang, Hunan, China
Affiliated Hospital of Nantong University
Nantong, Jiangsu, China
Start Date
January 1, 2023
Primary Completion Date
August 31, 2024
Completion Date
November 30, 2024
Last Updated
December 30, 2022
Lead Sponsor
Eastern Hepatobiliary Surgery Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions